IDWeek 2024

The Section on Infectious Diseases and Atrium Health Division of Infectious Diseases attended IDWeek 2024 in Los Angeles, CA and was well represented!

Research
Publication
Author
Affiliation
Published

October 16, 2024

Doi

The Section on Infectious Diseases and the Atrium Health Division of Infectious Diseases attended IDWeek 2024 in Los Angeles, CA and made a strong showing. Presentations and posters were presented by a variety of members including infectious diseases pharmacists, pharmacy residents, medical residents,infectious disease fellows, and infectious disease physicians.

Poster Presentations

  • Impact of a preoperative in-person assessment (PIPA) on Hip and Knee Replacement Surgical Site Infections (SSI) (Presenter: Anupama Neelakanta)

  • Exploring the association between penicillin allergy labels (PAL), beta-lactam utilization and surgical site infections (Presenter: Rupal Jaffa)

  • No targets, no problem: evaluation of patients with bloodstream infections without a molecular target detected by a rapid diagnostic assay (Presenter: Julie Williamson)

  • Differential impact of a penicillin allergy assessment tool on orthopedic surgical patients from areas of high social vulnerability (Presenter: Katie Passaretti)

  • Back to School! Improving Pharyngitis Care for School Students (Presenter: Lisa Davidson)

  • Evaluating the Impact of a Pharmacy Technician in an Antimicrobial Stewardship Program (Presenter: Lisa Davidson)

  • Shorter versus Longer Duration of Antibiotic Therapy for Gram-Negative Bacteremia (GNB) in Immunocompromised Patients (Presenter: Nicole Slain)

  • Antibiotic Inertia Occurs Frequently in Patients Admitted from the Emergency Department on Guideline Non-Concordant Therapy (Presenter: Adrianna Elashker)

  • Impact of Rapid Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Screening on Duration of Vancomycin Therapy for Suspected Pneumonia (PNA) in Adult Patients Admitted to the Trauma Intensive Care (Presenter: Alex D. Taylor)

  • Real-World Efficacy of Fosfomycin for Treatment of Cystitis Caused by E. coli Versus Non-E. coli Bacteria With High Rates of FosA (Presenter: Ryan C. McCormick)

  • Palliative medicine consultation does not reduce antimicrobial use during end-of-life care (Presenter: Hanna Akula)

  • Monocyte Distribution Width (MDW) as a Biomarker to Distinguish Septic Shock with Bacteremia from Cardiogenic Shock (Presenter: Kaylie Goldner)

Oral Presentations

  • Three days of antibiotics for uncomplicated CAP: Ready for Prime Time? (Lisa Davidson)

  • Impact of Universal Nasal Decolonization with an Alcohol-Based Nasal Antiseptic (ABNA) Versus Mupirocin on Infection Rates and Antimicrobial Utilization in Patients (Pts) Admitted to the Burn Service (Alex D. Taylor)

  • Evaluation of Fecal Pharmacokinetics and Metagenomic Changes Following the Administration of Intravenous Omadacycline to Healthy Patients (Co-author: John C. Williamson)

Pre-meeting workshops

  • Exapnding your influence to Improve Antibiotic Use in Outpatient settings (Lisa Davidson)

Reuse

Citation

BibTeX citation:
@online{e._dewitt2024,
  author = {E. DeWitt, Michael},
  title = {IDWeek 2024},
  date = {2024-10-16},
  url = {https://wakeforestid.com/posts/2024-10-16-idweek2024/},
  doi = {10.59350/kygvg-kc478},
  langid = {en}
}
For attribution, please cite this work as:
E. DeWitt, Michael. 2024. “IDWeek 2024.” October 16, 2024. https://doi.org/10.59350/kygvg-kc478.

Share